期刊文献+

心房颤动对NT-proBNP诊断急性心力衰竭的影响 被引量:2

Influence of atrial fibrillation on NT-proBNP for diagnosing acute heart failure
下载PDF
导出
摘要 目的:分析心房颤动(AF)对氨基末端脑钠肽前体(NT‐proBNP)用于诊断急性心力衰竭(AHF)的影响。方法收集因急性呼吸困难住院疑诊 AHF 并于入院24 h 内行 NT‐proBNP 检测和心电图检查的患者457例,根据是否确诊 AHF 及入院心电图是否合并 AF 分组,AHF 合并 AF(AHF + AF)组65例;AHF 不合并 AF(AHF + non AF)组50例;非 AHF 合并 AF(non AHF + AF)组63例;非 AHF 不合并 AF(non AHF + non AF)组10例。用受试者工作特征曲线(ROC 曲线)评估 NT‐proBNP 诊断 AHF 的价值。结果457患者中,确诊 AHF 者194例(42.5%),AF 者140例(30.6%)。 AF 组 NT‐proBNP 水平显著高于non AF 组(4482.0 pg/mL vs .1302.0 pg/mL ,P<0.01),AHF + AF 组与 AHF + non AF 组 NT‐proBNP 水平差异无统计学意义(6580.0 pg/mL vs .6769.0 pg/mL ,P >0.05),non AHF + AF 组 NT‐proBNP 水平较 non AHF + non AF 组显著升高(2892.0 pg/mL vs .403.3 pg/mL ,P<0.01)。 AF 组与 Non AF 组 NT‐proBNP 诊断 AHF 的曲线下面积分别为0.759(95% CI :0.677~0.841,P<0.01),0.931(95% CI :0.903~0.985,P<0.01)。结论 NT‐proBNP 水平在非急性心力衰竭的房颤者中显著升高,可能影响其在 AHF 中的诊断价值,临床应用时,为更好地解读 NT‐proBNP 结果,需注意患者是否为房颤心律。 Objective To analyze the influence of atrial fibrillation(AF) on N‐terminal pro‐brain natriuretic peptide(NT‐proB‐NP) for the assist diagnosis of acute heart failure(AHF) .Methods Totally 457 inpatients with suspected AHF due to acute dysp‐nea and conducting blood NT‐proBNP detection and electrocardiogram(ECG) within 24 h of admission were collected and devided into groups according to whether AHF was diagnosed and complicated with AF identified by ECG on admission ,that was AHF +AF group ,AHF + non AF group ,non AHF + AF group ,non AHF + non AF group .The receiver operating characteristic (ROC) curve was adopted to evaluate the value of NT‐proBNP for diagnosing AHF .Results Among 457 cases ,194 cases (42 .5% ) were diagnosed as AHF and 140 cases (42 .5% ) as AF .The NT‐proBNP level in the AF group was significantly higher than that in the non AF group (4 482 .0 pg/mL vs .1 302 .0 pg/mL ,P 〈 0 .01) .The NT‐proBNP level had no statistical difference between the AHF + AF group and the AHF + non AF group AF(6 580 .0 pg/mL vs .6 769 .0 pg/mL ,P〉 0 .05) .The NT‐proBNP level in the non AHF + AF group was significantly increased compared with the non AHF + non AF group (403 .3 pg/mL vs .2 892 .0 pg/mL ,P〈 0 .01) .The area under the curve(AUC) of NT‐proBNP for diagnosing AHF in the AF group and the non AF group was 0 .759(95% CI :0 .677 - 0 .841 ,P 〈 0 .01) and 0 .931(95% CI :0 .903 - 0 .985 ,P 〈 0 .01) .Conclusion The NT‐proBNP level in AF patients without AHF is significantly increased ,which might affect the value of NT‐proBNP in the diagnosis of AHF .In the clinical applica‐tion ,whether the patient has AF cardiac rhythm should be paid attention to for better interpretating the detection result of NT‐proBNP .
作者 段芹 张冬颖
出处 《重庆医学》 CAS CSCD 北大核心 2014年第36期4917-4919,共3页 Chongqing medicine
关键词 氨基末端脑钠肽前体 心房颤动 急性心力衰竭 ROC 曲线 N-terminal pro-brain natriuretic peptide atrial fibrillation acute heart failure ROC curve
  • 相关文献

参考文献17

  • 1McMurray J J, Adamopoulos S, Anker SD, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 :The Task Force for the Diag- nosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association(HFA) of the ESC[J]. Eur J Heart Faii,2012,14(8) :803-869.
  • 2Weitraub NL,Collins SP,Pang PS,et al. Acute heart fail- ure syndrome: emergency department presentation, treat- ment, and disposition: current approaches and future aims:a scientific statement from the Amercian Heart As-sociation[J]. Circulation,2010,122(19) :1975-1996.
  • 3急性心力衰竭诊断和治疗指南[J].中华心血管病杂志,2010,38(3):195-208. 被引量:835
  • 4Mollmann H, Weber M, Elsasser A, et al. NT-proBNP predicts rhythm stability after eardioversion of lone atrial fibrillation[J]. Cite J, 2008,72 (6) : 921-925.
  • 5Daeieek V, Theodorovieh N, Bar-Chaim S, et al. Sinus rhythm restoration after atrial {ihrillatiom the clinical val- ue of N-terminal pro-BNP measurementsEJ2. Pacing Clin Electrophysiol, 2008,31 (8) : 955-960.
  • 6钟淼,史若飞.心房颤动患者血清BNP、hsCRP、CK-MB的变化及意义[J].第三军医大学学报,2009,31(8):710-712. 被引量:11
  • 7Patrick R, Sophie B, Yannick L, et al. Acute respiratory failure in the elderly: etiology, emergency diagnosis and prognosis[J]. Crit Care, 2006,10 ( 3 ) R82.
  • 8Pedram KP, Gavin GO, Bodh IB. Atrial fibrillation and heart failure in the elderly. Heart Fail Rev, 2012, 17 (4) :597-613.
  • 9Lloyd-Jones DM,Larson MG,Leip EP et al. Lifetime risk for developing congestive heart failure., the Framingham Heart Study[J]. Circulation, 2002,106 (24) : 3068-3072.
  • 10Januzzi JL Jr,Camargo CA, Anwaruddin S, et al. The N- terminal Pro-BNP investigation of dyspnea in the emer- gency department(PRIDE)study[J]. Am J Cardiol, 2005, 95(8) 948- 954.

二级参考文献50

  • 1谢洪智,朱文玲.重组人脑利钠肽和硝酸甘油治疗急性失代偿性心力衰竭疗效和安全性的随机、开放、平行对照的多中心临床研究[J].中华心血管病杂志,2006,34(3):222-226. 被引量:228
  • 2孙晓红,彭晓玲,周莲英.血清高敏C反应蛋白与心房颤动[J].岭南心血管病杂志,2006,12(2):98-100. 被引量:21
  • 3中华医学会心血管病学分会 中华心血管病杂志编辑委员会.β肾上腺素能受体阻滞剂在心血管疾病应用的专家共识[J].中华心血管病杂志,2009,37:195-209.
  • 4Silver H, Young-Xu Y, Walleigh D, et al. Brain natriuretie peptide is elevated in outpatients with atrial fibrillation[ J]. Am J Cardiol, 2003, 92(9) : 1124 -1127.
  • 5Hirata Y, Matsumoto A, Aoyagi T, et al. Measurement of plasma brain natriurctic peptide level as a guide for cardiac overload[J]. Cardiovasc Res, 2001, 51(3): 585-591.
  • 6Cheng V, Kazanagra R, Garcia A, et al. A rapid bedside test for B- type peptide predicts treatment outcomes in patients admitted for decompensated heart failure: a pilot study[ J]. J Am Coll Cardiol, 2001, 37(2) : 386 -391.
  • 7Libby P, Ridker P M. Inflammation and atherosclerosis: role of C-reactive protein in risk assessment [ J ]. Am J Med, 2004, 116 ( Suppl 6A) : 9S - 16S.
  • 8中华医学会心血管病学分会 中华心血管病杂志编辑委员会.慢性心力衰竭诊断治疗建议.中华心血管病杂志,2007,35(12):1076-1095.
  • 9Nieminen MS, Bohm M, Cowie MR, et al. Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology. Eur Heart J, 2005, 26: 384-416.
  • 10Task Force for Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of European Society of Cardiology. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008 : the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC ( HFA ) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J, 2008, 29 : 2388-2442.

共引文献844

同被引文献15

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部